Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Mid Cap Fund median (32 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | DSP Midcap Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹96.53 |
| 12 Apr 2015 | ₹185.47 |
| 31 May 2016 | ₹187.08 |
| 19 Jul 2017 | ₹262.45 |
| 07 Sep 2018 | ₹282.43 |
| 27 Oct 2019 | ₹281.88 |
| 15 Dec 2020 | ₹321.83 |
| 03 Feb 2022 | ₹379.56 |
| 25 Mar 2023 | ₹282.11 |
| 12 May 2024 | ₹401.39 |
| 01 Jul 2025 | ₹446.25 |
| 20 Aug 2026 | ₹443.40 |
| Metric | DSP · Direct · IDCW NAV ₹71.00 Very High risk ★★☆☆☆ | Category median Mid Cap Fund · 32 funds |
|---|---|---|
| -1.02% | +6.29% | |
| +7.77% | +14.78% | |
| +4.17% | +13.99% | |
| +7.48% | +9.73% | |
| +11.55% | +15.68% | |
| +6.01% | — | |
| +12.49% | +16.53% | |
| +11.06% | +14.94% | |
| +11.64% | +12.00% | |
| Risk | ||
| 17.72% | 16.93% | |
| 0.07 | 0.53 | |
| 0.09 | 0.73 | |
| -38.93% | -36.26% | |
| Nifty Midcap 150 | — | |
| -9.20% | -2.10% | |
| 1.05 | 0.97 | |
| 86.9% | 93.0% | |
| 128.8% | 95.9% | |
| 0.82% | 0.95% | |
| ₹19,539Cr | ₹7,889Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 9% | 40% | |
| Vinit Sambre | — | |
| 02 Jan 2013 | — | |
| 63 | — | |
| 27.2% | — | |
| 4.3% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.